Ucb Biosciences Inc.: Cimzia (certolizumab Pegol), 2x200mg/ml Prefilled Syringes (2 Single-dose)
UCB Biosciences is recalling Cimzia (certolizumab pegol) 200mg/mL prefilled syringes distributed nationwide because the company cannot confirm the products remain sterile. The recall affects multiple product formats, including individual packages and starter kits. People who received this medication should contact their healthcare provider or pharmacist about their specific prescription.
- Recalling firm
- UCB Biosciences Inc.
- Product
- cimzia (certolizumab pegol), 2x200mg/mL PREFILLED SYRINGES (2 single-dose), Rx ONLY, Manufactured by: UCB Inc., Smyrna, GA 30080, a) NDC 50474-710-79, b) Professional sample, NDC 50474-710-80; c) 3 cartons, STARTER KIT, NDC 50474-710-81.
- Reason
- Lack of Assurance of Sterility
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-05-08
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- US Nationwide.
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/aef25225-e831-4407-b142-5be9c5f7a98c